BioSpace News Archive

Drug Development

AnGes MG Inc. Starts Global Phase 3 Clinical Trials Of Collategene® For Critical Limb Ischemia

October 6, 2014
·
2 min read
Drug Development

Foamix Pharmaceuticals, Ltd. Announces Initiation Of Phase 2 Trial With FDX104 In Chemotherapy Induced Rash

October 6, 2014
·
4 min read
Business

Trinity Biotech To Announce Third Quarter Fiscal 2014 Financial Results

October 6, 2014
·
2 min read
Lone Star Bio

Savara Reels In $10 Million

October 6, 2014
·
3 min read
Biotech Bay

Cesca Therapeutics To Present At Stem Cell Meeting On The Mesa

October 6, 2014
·
3 min read
Drug Development

Capricor Therapeutics, Inc. Announces Plans To Pursue Clinical Program For The Treatment Of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs)

October 6, 2014
·
4 min read
Biotech Bay

Human Longevity Inc. Adds Pacific Biosciences® Sequencing To Enable Additional Insight Into Human Genetic Variation

October 6, 2014
·
4 min read
Sanomedics International Holdings Inc. Reduces Liabilities As It Continues To Strengthen Balance Sheet

October 6, 2014
·
2 min read
Drug Development

AcelRx Pharmaceuticals Release: Sufentanil Sublingual Tablet System Study Results To Be Presented At The International Association For The Study Of Pain Meeting

October 6, 2014
·
3 min read
Drug Development

Data From Alder Biopharmaceuticals Inc.’ Proof-Of-Concept Clinical Trial Of ALD403 Published In Lancet Neurology Demonstrates ALD403 Effective In The Preventive Treatment Of Migraine

October 6, 2014
·
4 min read